[
    [
        {
            "time": "2018-11-28",
            "original_text": "格隆汇港股聚焦(11.28)︱波司登中期纯利上升36.4%至3.43亿元 复星医药在研白血病新药获美国孤儿药认定",
            "features": {
                "keywords": [
                    "波司登",
                    "中期纯利",
                    "复星医药",
                    "白血病新药",
                    "孤儿药认定"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "服装"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(11.28)︱波司登中期纯利上升36.4%至3.43亿元 复星医药在研白血病新药获美国孤儿药认定",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-11-28",
            "original_text": "复星医药(02196)：FN-1501治疗急性髓性白血病获美国FDA孤儿药认定",
            "features": {
                "keywords": [
                    "复星医药",
                    "FN-1501",
                    "急性髓性白血病",
                    "FDA",
                    "孤儿药认定"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196)：FN-1501治疗急性髓性白血病获美国FDA孤儿药认定",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-11-28",
            "original_text": "复星医药(600196.SH)：白血病新药FN-1501获美国FDA孤儿药认定",
            "features": {
                "keywords": [
                    "复星医药",
                    "白血病新药",
                    "FN-1501",
                    "FDA",
                    "孤儿药认定"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：白血病新药FN-1501获美国FDA孤儿药认定",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-11-27",
            "original_text": "智通港股通持股分析|11月27日",
            "features": {
                "keywords": [
                    "智通港股通",
                    "持股分析"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智通港股通持股分析|11月27日",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]